DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Wechalekar AD, Goodman HJ, Lachmann HJ et al.
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis.
Blood 2007;
109: 457-464
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.